Web Content Management
PRODUCTS
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Our team of experts are equipped to guide you through every step of any Inspection, especially Pre-Approval Inspections, due to the nature of their criticality.
-
For your efficient and error-proof production: Our world-leading Manufacturing Execution System (MES) Suite PAS-X controls, monitors, and documents your processes digitally and in real time throughout the entire manufacturing cycle.
-
By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.
WHITE PAPERS AND CASE STUDIES
-
Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer
This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.
-
Laerdal Error-Proofs Medical Kit Assembly With AI-Powered Vision Verifications
Discover how Laerdal Medical implemented an automated kit assembly solution that enhances quality control and supports continuous improvement through real-time monitoring and visual documentation.
-
A Synergy Of Excellence: Partnership During Unprecedented Times
Learn how a partner with the right experience and capabilities is crucial to support accelerated GMP manufacturing and ensure novel vaccines and therapeutics receive regulatory approval.
-
Trial Rescue: Leadership Approach To Propel Clinical Development
Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.
-
How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges
Learn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Overcoming Participant Compliance Challenges In A Medical Device Study
Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.
-
Digital Transformation - The Power Of Your Data
Discover how you can circumvent numerous recirculations during the ultrafiltration process step, boost downstream bioprocess yield, and identify and resolve process inefficiencies.
-
Improving Patient Health And Safety: Medical Affairs
A medical affairs department needed leaders with scientific and project management expertise. With no time for training or risk tolerance, a consultant was hired to align activities with development and launch plans.
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
Advancing From Single Country Phase 1 Success To Multinational Phase 1/2 Trial
Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.
NEWS
-
GoGoGrandparent Launches New Advocacy Program For Seniors: GoGoCare Goes Beyond Rides And Deliveries To Help Members Navigate Complex Healthcare Situations7/7/2025
GoGoGrandparent, the first on-demand ride, delivery and care services designed to help aging adults continue to live independently, today announced that after a successful pilot, its GoGoCare advocacy program for members is now available across the U.S.
-
BioLargo Invited To Showcase PFAS Treatment Technology At Industry Leading Water Conference3/10/2025
BioLargo, Inc. a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that it will present data demonstrating industry-leading PFAS removal and destruction from landfill leachate (the contaminant-laden water that drains from landfills) at the Air & Waste Management Association's (A&WMA) "The Science of PFAS" conference on March 12, 2025 (https://www.awma.org/pfas).
-
Microbes In Brooklyn Superfund Site Teach Lessons On Fighting Industrial Pollution4/15/2025
NYU Tandon-led research team discovers unprecedented genetic adaptations in Gowanus Canal organisms, revealing a potential new approach for cleaning contaminated waters and recovering valuable resources.
-
BIoNTX And The Cleanroom Center Launch Strategic Hub For Drug Manufacturing In Dallas7/28/2025
The Cleanroom Center has launched its global headquarters in Dallas, partnering with BioNTX to help life science and advanced manufacturing companies accelerate cleanroom selection and deployment
-
Serve Robotics To Acquire Diligent Robotics, Expanding Physical AI Platform Beyond The Sidewalk1/20/2026
Serve Robotics Inc. (Nasdaq: SERV) (“Serve” or “the Company”), a leading autonomous robotics company, today announced that it has entered into an agreement to acquire Diligent Robotics, Inc. (“Diligent”), a pioneering provider of AI-powered robot assistants for the healthcare industry.